Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2376804
Max Phase: Preclinical
Molecular Formula: C14H18N6
Molecular Weight: 270.34
Molecule Type: Small molecule
Associated Items:
ID: ALA2376804
Max Phase: Preclinical
Molecular Formula: C14H18N6
Molecular Weight: 270.34
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CNC1CN(c2nc(N)nc3cc(C4CC4)cnc23)C1
Standard InChI: InChI=1S/C14H18N6/c1-16-10-6-20(7-10)13-12-11(18-14(15)19-13)4-9(5-17-12)8-2-3-8/h4-5,8,10,16H,2-3,6-7H2,1H3,(H2,15,18,19)
Standard InChI Key: KICLSPYVVBSUFF-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 270.34 | Molecular Weight (Monoisotopic): 270.1593 | AlogP: 0.89 | #Rotatable Bonds: 3 |
Polar Surface Area: 79.96 | Molecular Species: BASE | HBA: 6 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 8.72 | CX LogP: 1.45 | CX LogD: 0.11 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.86 | Np Likeness Score: -0.67 |
1. Andaloussi M, Lim HD, van der Meer T, Sijm M, Poulie CB, de Esch IJ, Leurs R, Smits RA.. (2013) A novel series of histamine H4 receptor antagonists based on the pyrido[3,2-d]pyrimidine scaffold: comparison of hERG binding and target residence time with PF-3893787., 23 (9): [PMID:23558237] [10.1016/j.bmcl.2013.02.091] |
Source(1):